Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01172 |
| Species: | Homo sapiens |
| Position : | chr2:217920100-217921400 |
| Year: | 2014 |
| Title: | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cutaneous melanoma |
| PMID: | 25248036 |
| MONDO: | MONDO:0005012 |
| Tissue: | zone of skin |
| Tissue Ontology ID: | UBERON:0000014 |
| Cell Source: | GA-10 clone 4 |
| CVCL ID: | CVCL_1224 |
| Cell Type: | melanoma cell |
| Experiment Type: | Enhancer activity assay |
| Low Throughput Method: | Luciferase Reporter Assay |
| Target gene : | IGFBP5 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01154 | chr2:217918268-217921910 | breast | malignant cell | Breast Cancer |